Brisk sale on injectable devices is seen

Published: 2003-09-18 06:57:00

Updated: 2003-09-18 06:57:00

Following a tougher pharmaceutical inspection of the Korea Food and Drug Administration on KGMP-accredited firms every year, pharmaceutical equipment makers project that a number of pharmaceutical firms may replace their old machinery and equipments and purchase new ones to meet the KFDA's strict...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK